Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-046954
Filing Date
2024-11-20
Accepted
2024-11-20 12:52:57
Documents
53
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1057967
2 ex31-1.htm EX-31.1 12489
3 ex31-2.htm EX-31.2 12266
4 ex32-1.htm EX-32.1 7971
  Complete submission text file 0001493152-24-046954.txt   4596545

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tsoi-20240930.xsd EX-101.SCH 29897
6 XBRL CALCULATION FILE tsoi-20240930_cal.xml EX-101.CAL 56273
7 XBRL DEFINITION FILE tsoi-20240930_def.xml EX-101.DEF 126129
8 XBRL LABEL FILE tsoi-20240930_lab.xml EX-101.LAB 276229
9 XBRL PRESENTATION FILE tsoi-20240930_pre.xml EX-101.PRE 216868
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 574687
Mailing Address 701 WILD ROSE LANE ELK CITY ID 83525
Business Address 701 WILD ROSE LANE ELK CITY ID 83525 (760) 295-7208
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (Filer) CIK: 0001419051 (see all company filings)

EIN.: 451226465 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54554 | Film No.: 241479564
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)